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Background: Although hypoxia is known to promote hepatoma cell invasion and migration, little is known
regarding the molecular mechanisms of this process. Our previous research showed that loss of Tg737 is associated
with hepatoma cell invasion and migration; therefore, we hypothesized that the Tg737 signal might be required for
hypoxia-enhanced invasion and migration.
Methods: We established in vitro normoxic or hypoxic models to investigate the role of Tg737 in the
hypoxia-enhanced invasion and migration of hepatoma cells. The hepatoma cell lines HepG2 and MHCC97-H were
subjected to normoxic or hypoxic conditions, and the cell adhesion, invasion, and migration capabilities were
tested. The expression of Tg737 under normoxia or hypoxia was detected using western blot assays; cell viability
was determined using flow cytometry. Furthermore, we created HepG2 and MHCC97-H cells that over expressed
Tg737 prior to incubation under hypoxia and investigated their metastatic characteristics. Finally, we analyzed the
involvement of critical molecular events known to regulate invasion and migration.
Results: In this study, Tg737 expression was significantly inhibited in HepG2 and MHCC97-H cells following
exposure to hypoxia. The down regulation of Tg737 expression corresponded to significantly decreased adhesion
and increased invasion and migration. Hypoxia also decreased the expression/secretion of polycystin-1, increased
the secretion of interleukin-8 (IL-8), and increased the levels of active and total transforming growth factor β 1
(TGF-β1), critical regulators of cell invasion and migration. Moreover, the decrease in adhesiveness and the increase
in the invasive and migratory capacities of hypoxia-treated hepatoma cells were attenuated by pcDNA3.1-Tg737
transfection prior to hypoxia. Finally, following the up regulation of Tg737, the expression/secretion of polycystin-1
increased, and the secretion of IL-8 and the levels of active and total TGF-β1 decreased correspondingly.
Conclusions: These data provide evidence that Tg737 contributes to hypoxia-induced invasion and migration,
partially through the polycystin-1, IL-8, and TGF-β1 pathway. Taken together, this work suggests that Tg737 is
involved in the invasion and migration of hepatoma cells under hypoxia, with the involvement of the polycystin-1,
IL-8, and TGF-β1 signaling pathway. Tg737 is a potential therapeutic target for inhibiting the high invasion and
migration potential of hepatoma cells in hypoxic regions.
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Hepatocellular carcinoma (HCC) is among the most
common malignancies, with an increasing incidence in
China [1]. Despite surgical and locoregional therapies,
the prognosis remains poor because of local invasion
and the high rate of intra-hepatic and distant metastases
after resection or transplantation [2]. Invasion and me-
tastasis have become major challenges that must be
overcome for the effective treatment of HCC. Thus,
advances in treatments for this disease are likely to de-
velop from a better understanding of the mechanisms of
invasion and metastasis.
In HCC, tissue oxygenation measurements have revealed
large areas of hypoxic tissue, and the expression of hypoxic
markers has been correlated with rapid invasion and metas-
tasis, short overall survival, and short time to recurrence. It
has been established that hypoxia is an important micro-
environmental factor in prompting tumor invasion and me-
tastasis [3]. Under hypoxic conditions, cells invasion and
metastasis involve several sequential steps and a large num-
ber of altered molecules (such as cytokines, chemokines
and their receptors, and growth factors) [4,5]. However, the
precise and key molecular events that initiate this crucial
turning point remain unknown, and this knowledge gap
can lead to delays in diagnosis and poor treatment.
The Tg737 gene (GenBank: U203621) is an important
tumor suppressor gene in HCC [6]. In a previous investiga-
tion, we showed that loss of heterozygosity (LOH) of the
Tg737 gene at markers SHGC-57879 and G64212 closely
correlates with tumor node metastasis (TNM) stage and
with HCC metastasis, indicating that these two markers
can be detected independently and used to predict tumor
stage and metastasis in HCC patients [7]. We further found
that reduced expression of Tg737 greatly promotes cell in-
vasion and hepatocarcinogenesis of fetal liver stem/progeni-
tor cells (FLSPCs) [8]. Based on the above findings, we
hypothesized that Tg737 might play an important role in
HCC invasion and metastasis. However, whether Tg737
plays a role in hypoxia-induced invasion and migration of
HCC cells has not been reported. It is of paramount im-
portance to gain this knowledge, not only to increase our
understanding of tumor biology but also to permit the de-
velopment of specific therapies that effectively target HCC.
The aim of this study was to investigate whether
Tg737 correlates with hypoxia-induced HCC invasion
and metastasis and to determine the underlying mechan-
isms of invasion and metastasis under hypoxic condi-
tions. As we speculated, following exposure of HCC
cells to hypoxia, downregulation of Tg737 is required for
a significant increase in invasion and migration in vitro
via the downregulation of polycystin-1 expression/secre-
tion and the upregulation of interleukin-8 (IL-8) secre-
tion and active and total transforming growth factor β 1
(TGF-β1) levels. To our knowledge, this is the firstreport demonstrating that Tg737 contributes to hypoxia-
induced invasion and migration in HCC cells. The
results of this research indicate that Tg737 may play a
role in HCC gene therapy and should be investigated
further.
Materials and methods
Cell line and culture condition
HepG2 and MHCC97-H cells (maintained in our labora-
tory, originally obtained from the Cell Bank of Type Cul-
ture Collection of the Chinese Academy of Sciences),
were cultured in Dulbecco's Modified Eagle Medium
(DMEM) supplemented with 10% fetal bovine serum
(FBS; Invitrogen, Carlsbad, CA, USA), 100 IU/ml peni-
cillin, 400 IU/L trypsin, and 100 μg/ml streptomycin and
were plated in 75-cm2 flasks and cultured at 37°C with
5% CO2 and 95% humidified air. The medium was chan-
ged every 2 days. In all subsequent related experiments,
the HepG2 and MHCC97-H cells were treated with
medium supplemented with 1% FBS, unless otherwise
noted. For the incubation of cells under hypoxic condi-
tions, the cells were exposed to 1% O2 with 5% CO2 at
37°C for the indicated times.
Annexin V/propidium iodide (PI) assay
To exclude the possibility of apoptosis-related effects in
subsequent experiments, Annexin V/propidium iodide
assays were performed. After 18 h of incubation with
medium supplemented with 1% FBS under normoxic or
hypoxic conditions at 37°C, the cells were harvested,
washed in cold phosphate-buffered saline (PBS), incu-
bated for 15 min with fluorescein-conjugated Annexin V
and PI and analyzed using flow cytometry. The cells
incubated with medium supplemented with 10% FBS
under normoxic conditions were also analyzed.Adhesion assay
An adhesion assay was performed in 12-well plates as
described elsewhere [9]. After 10 h of incubation with
medium supplemented with 1% FBS at 37°C under nor-
moxic or hypoxic conditions, the cells were harvested,
resuspended (1 × 105 in 1.5 ml of DMEM supplemented
with 1% FBS), plated onto collagen surfaces, and allowed
to adhere for 2 h, consistent with the previous condi-
tions (normoxia or hypoxia). The unbound cells were
removed by washing twice with PBS, and the adherent
cells were counted under a microscope at 200× magnifi-
cation from 10 random fields in each well. Each experi-
ment was performed in triplicate.
Cell invasion and migration assays
Cell migration was assayed using transwells with 8-μm
pore filters (Costar, MA, USA). The lower chamber was
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5 μg/ml of fibronectin (Sigma, St. Louis, MO, USA), and
2 × 104 cells in 0.5 ml of media supplemented with 1%
FBS were loaded into the upper chamber. After 12 h of
normoxic or hypoxic treatment, the cells that migrated
to the bottom surface of the membrane were fixed with
4% formaldehyde and stained with 0.5% crystal violet
dye. The cells on the top surface of the membrane were
removed by wiping the surface with a cotton swab. The
numbers of migrated cells were counted at 200× magni-
fication from 10 different microscopic fields. For the
Matrigel invasion assay, the procedures were the same
as described above, except that the transwell membrane
was coated with 500 ng/μl of Matrigel (BD, CA, USA).
Protein extraction and western blot analyses
After being cultured in DMEM supplemented with 1%
FBS under normoxic or hypoxic conditions for 12 h, the
cells were processed for protein extraction, and western
blot assays were performed according to the published
method [10]. The primary antibodies were anti-glyceral-
dehyde-3-phosphate dehydrogenase (GAPDH) (diluted
1:400, Santa Cruz Biotechnologies, Santa Cruz, CA,
USA) and anti-Tg737 (diluted 1:600, Abnova, Taipei,
Taiwan). The grayscale values of each band on the blots
were measured using BandScan 4.3. The cells incubated
with medium supplemented with 10% FBS under normoxic
conditions were also analyzed.
Construction of the targeting vector
The pcDNA3.1-Tg737 plasmid was commercially con-
structed by the GeneChem Company (Shanghai, China)
and was used for transient transfections. Briefly, the Tg737
coding sequence was amplified using the polymerase
chain reaction (PCR) technique. Total RNA from normal
human liver tissue was isolated with Trizol (Invitrogen).
Normal human liver tissue was obtained from patients
who consented to the procedure during a laparotomy and
hepatic resection. The tissues were acquired following ap-
proval by the local medical research ethics committee at
Xijing Hospital, the Fourth Military Medical University,
Xi’an, China. A High Fidelity PrimeScript reverse tran-
scription PCR kit (TaKaRa, Dalian, China) was used to
synthesize cDNA according to the manufacturer’s proto-
col. The PCR was performed with the primer set P1, 5’-
TCCGCTCGAGATGAAATTCACAAACACTAAGGTAC-3’
(forward) and P2, 5’-ATGGGGTACCTTATTCTGGAA
GCAAATCATCTCCT-3’ (reverse), containing XhoI
and KpnI sites, respectively, using the obtained cDNA
as a template. The following cycling conditions were
used: initial denaturation at 94°C for 5 min; 30 cycles of
denaturation at 94°C for 10 s, annealing at 55°C for
30 s, and extension at 72°C for 2 min; and a final exten-
sion at 72°C for 10 min. After digestion using XhoI andKpnI enzymes, the PCR product was cloned into the
pcDNA3.1 (−) vector (GnenChem, Shanghai, China)
digested using the same enzymes; the resultant recom-
binant plasmid was designated pcDNA3.1-Tg737.
Transient transfection and cell adhesion, invasion and
migration assays
The pcDNA3.1-Tg737 plasmid was transiently trans-
fected into HepG2 and MHCC97-H cells using Lipofec-
tamineTM 2000 (Invitrogen). All of the procedures were
performed according to the manufacturer’s instructions.
The cells transfected with pcDNA3.1 (−), those incu-
bated with LipofectamineTM 2000 alone and those with-
out plasmid transfection were established as controls.
Six hours after transfection, transiently pcDNA3.1-
Tg737-transfection cells and controls were subjected to
the analyses described above. In brief, the cells were
incubated with fresh DMEM (1% FBS) for 12 h under
hypoxia and were then subjected to western blot analysis
for Tg737 expression. After 10 h of incubation under
hypoxia, the cells underwent an adhesion assay. Further-
more, the cells (approximately 2 × 104 cells) in 0.5 ml of
media supplemented with 1% FBS were plated into the
top chamber of a transwell and were incubated for 12 h
under hypoxic conditions for the migration and invasion
assays. After 12 h of incubation under hypoxia, Annexin
V/propidium iodide assays were also performed to ex-
clude apoptosis-related effects.
Western blot assay for polycystin-1
To measure the polycystin-1 expression levels of the dif-
ferent cells (indicated in the Results and Figure Legends
sections), western blot assays were performed using the
techniques described above. The primary antibodies
used were anti-polycystin-1 (diluted 1:600, Santa Cruz)
and anti-GAPDH (diluted 1:400, Santa Cruz).
Enzyme-linked immunosorbent assay (ELISA)
For quantification of polycystin-1, IL-8 and TGF-β1 pro-
tein secretion by different cells, culture medium was col-
lected and centrifuged at 6000 r/min for 10 min. The
supernatant was used for determination of protein secre-
tion with ELISA kits (Cusabio, Wuhan, China) according
to the manufacturer’s protocol. The antibodies used in
the TGF-β1 ELISA kit are only able to detect TGF-β1 in
its active form; thus, the samples were activated by acid-
ification before ELISA to determine the amount of total
TGF-β1.
Statistical analysis
SPSS software, version 14.0, was used for all statistical
evaluations. The data are presented as the means ±
standard errors of the mean for separate experiments
(n ≥ 3, where n represents the number of independent
You et al. Journal of Experimental & Clinical Cancer Research 2012, 31:75 Page 4 of 13
http://www.jeccr.com/content/31/1/75experiments). The data were analyzed for significance
using a one-way ANOVA; P < 0.05 was considered
significant.
Results
Hypoxia reduced HCC cell adhesion and facilitated
invasion and migration
To examine the effects of hypoxia on HCC cell adhe-
sion, migration, and invasion, two human HCC cell
lines, HepG2 and MHCC97-H, were exposed to either
normoxia or hypoxia under the same media conditions.
An adhesion assay revealed that exposure of these two
HCC cell lines to hypoxic conditions decreased their
capacity to adhere to collagen (Figure 1A). Next, HCC
cell migration through a microporous membrane and in-
vasion through an extracellular matrix were assessed
under normoxic and hypoxic conditions. It was observed
that exposure of these two HCC cell lines to hypoxic
conditions resulted in significant increases in invasion
(Figure 1B and C) and migration (Figure 1D and E)
in vitro. To exclude the effects on cell viability after treat-
ment with low-serum medium under normoxic or hyp-
oxic conditions, we performed Annexin V assays. We
found that over the course of the experiment, the treat-
ment of HepG2 and MHCC97-H cells with low-serum
medium under normoxic or hypoxic conditions did not
significantly affect cell viability in vitro (Figure 2A and B).
Hypoxia induced the downregulation of Tg737 expression
in HCC cells
To determine whether Tg737 played a role in the
decreased adhesion and increased invasion and migration
capacity of hypoxia-treated HCC cells, western blot assays
were used to detect Tg737 expression. Under the same
media conditions, the exposure of HepG2 and MHCC97-
H to hypoxia led to a significant decrease in Tg737 expres-
sion levels compared to cells exposed to normoxia
(Figure 3A and B). However, the treatment of HepG2 and
MHCC97-H cells with low-serum medium under nor-
moxia did not significantly affect Tg737 expression.
pcDNA3.1-Tg737 transfection prior to incubation in
hypoxia facilitated HCC cell adhesion and attenuated cell
migration and invasion
Following confirmation of the relationships among
changes in adhesion, invasion and migration capacity
and the downregulation of Tg737 expression in hypoxia-
treated HCC cells, we wished to further clarify whether
Tg737 played a role in this process. The Tg737 DNA
fragment was inserted into the pcDNA3.1 (−) vector.
The data in Additional file 1 and Additional file 2 in the
Supplemental Data section confirmed that the recom-
binant plasmid contained the correct, full-nucleotide se-
quence of the Tg737 gene.The pcDNA3.1-Tg737 plasmids were transiently trans-
fected into HepG2 and MHCC97-H cells; the Tg737 pro-
tein levels were then determined, and the adhesion,
invasion and migration experiments were repeated
under hypoxia. As shown in Figure 4A and B, when
pcDNA3.1-Tg737-transfection cells and cells without
plasmid transfection were incubated with DMEM sup-
plemented with 1% FBS for 12 h under hypoxia, western
blot analysis showed an increase in the Tg737 protein in
pcDNA3.1-Tg737-transfection cells, compared to cells
without plasmid transfection (n = 3, p < 0.05). These data
indicated that although the cells were transfected with
pcDNA3.1-Tg737 prior to incubation under hypoxia, the
pcDNA3.1-Tg737 used in this study was effective in pro-
moting the overexpression of the Tg737 gene in HepG2
and MHCC97-H cells. Furthermore, it was observed that
under the same media conditions, the overexpression of
Tg737 in HepG2 and MHCC97-H cells significantly
facilitated cell adhesion and attenuated cell invasion and
migration under hypoxic conditions compared to cells
without plasmid transfection under hypoxic conditions
(Figure 5A-E). To confirm that the effects of Tg737
overexpression on the facilitation of HCC cell adhesion
and on the attenuation of invasion and migration under
hypoxic conditions were not due to decreased cell viabil-
ity resulting from transfection with pcDNA3.1-Tg737,
we assessed the effect of pcDNA3.1-Tg737 transfection
on cell viability using Annexin V assays. As shown in
Figure 6A and B, the transfection of pcDNA3.1-Tg737
and subsequent hypoxia treatment did not affect cell via-
bility compared to cells without plasmid transfection
under hypoxic conditions. To exclude liposome/
pcDNA3.1 (−)-related effects on our study, we also ana-
lyzed cell viability and Tg737 expression, adhesion, inva-
sion and migration in HepG2 and MHCC97 cells
transfected with pcDNA3.1 (−) or incubated with Lipo-
fectamineTM 2000 prior to incubation in hypoxia. Cell
viability, Tg737 protein levels, and the adhesion, migra-
tion and invasion of these cells exhibited no significant
differences compared to cells without plasmid transfec-
tion (n = 3, P > 0.05). The results suggest that liposome/
pcDNA3.1 (−) had no effects in our study.
Polycystin-1, IL-8, and TGF-β1 were associated with the
contribution of Tg737 to hypoxia-induced adhesion,
migration, and invasion
To further explore the mechanism of action of Tg737 in
hypoxia-induced adhesion, migration, and invasion in
HCC cells, we examined the effects of Tg737 on the ex-
pression/secretion of polycystin-1 and the secretion of
IL-8 and TGF-β1, critical regulators of cell invasion and
migration. Our data indicated that polycystin-1 protein
expression/secretion was downregulated, whereas IL-8
secretion and the active and total TGF-β1 levels were
Figure 1 Hypoxia reduced HepG2 and MHCC97-H cell adhesion and facilitated invasion and migration. (A) An adhesion assay was
performed with HCC cells on collagen I-coated plates. The relative cell adhesion number in each group is reflected in the column chart. The
values of the normoxia-treated cells were set at 1. (B, C) Matrigel invasion assays of HepG2 and MHCC97-H cells were performed under normoxic
and hypoxic conditions; the quantified data are shown in the diagram. (D, E) Transwell migration assays of HepG2 and MHCC97-H cells were
performed under normoxic and hypoxic conditions; the numbers of cells are shown in the diagram. *, P< 0.05 compared to normoxia-treated
HepG2 cells; †, P< 0.05 compared to normoxia-treated MHCC97-H cells. Original magnification: 200× (B, D).
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Figure 2 (A) Representative dot plots showing the effects of low-serum medium under normoxic or hypoxic conditions on HepG2 and
MHCC97-H cell apoptosis. The cultured cells were treated for the indicated time periods and then stained with FITC-conjugated Annexin V and
PI. (B) The percentage of viable cells in each group is reflected in the column chart. I: cells incubated with medium supplemented with 10% FBS
under normoxia; II: cells incubated with medium supplemented with 1% FBS under normoxia; III: cells incubated with medium supplemented
with 1% FBS under hypoxia.
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terns were consistent with Tg737 downregulation com-
pared to normoxia-treated cells. Furthermore, the levels
of polycystin-1, IL-8, and TGF-β1 (active and total) in
hypoxia-treated HepG2 and MHCC97-H cells could be
recovered in both lines by transfection with pcDNA3.1-Tg737. The levels of polycystin-1, IL-8, and TGF-β1 (ac-
tive and total) were altered with the restored expression
of Tg737 (Figure 7A-D). Taken together, these results
demonstrated that Tg737 regulated hypoxia-induced ad-
hesion and that migration and invasion capabilities were
partially mediated by polycystin-1, IL-8 and, TGF-β1
Figure 3 Hypoxia inhibited Tg737 expression in HepG2 and
MHCC97-H cells. Western blot assay for Tg737 was performed;
GAPDH was used as a control.
Figure 4 Western blot assay was performed to determine the
expression levels of Tg737 in the different cells. The HepG2 and
MHCC97-H cells were transiently transfected with the pcDNA3.1-
Tg737 plasmid. To exclude liposome/vector-related effects, HepG2
and MHCC97-H cells transfected with pcDNA3.1 (−) or incubated
with LipofectamineTM 2000 alone were used as controls. HepG2 and
MHCC97-H cells without plasmid transfection also served as blank
controls. The cells were incubated with fresh DMEM (1% FBS) for
12 h under hypoxia, then lysed and subjected to immunoblot
analysis.
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ation of the extracellular matrix.
Discussion
The outcomes for patients with HCC remain dismal, al-
though a great deal has been learned regarding the dis-
ease over the past few decades. The capacity of cancer
cells to invade and metastasize to other locations in the
body remains a major obstacle for improving the sur-
vival and prognosis of HCC patients. Despite extensive
studies, a clear understanding of the mechanisms of the
invasion and metastasis processes and of how tumor
cells acquire these characteristic capabilities remains elu-
sive [11,12].
One factor that may play an important role in invasion
and metastasis is hypoxia, which commonly refers to a
condition in tissues in which the oxygen pressure is less
than 5–10 mmHg [13-15]. Hypoxia is a condition com-
monly found in a wide range of solid tumors including
HCC, and it is often associated with a poor prognosis
[16]. Recent studies have shown that HCC develops
through cirrhosis induced by chronic liver injury. This
chronic injury causes fibrogenesis, which demolishes the
normal liver blood system. Damage to the liver bloodsystem leads to a shortage of blood circulation in the
liver and consequently leads to hypoxia. Moreover, the
high proliferation of tumor cells also contributes to local
hypoxia in HCC [17]. Oxygen starvation causes the cells
to invade and migrate to distant sites and to colonize
organs in which nutrients and space are less limited.
Hypoxia potentially regulates each step of the invasion
and metastasis process, from the initial epithelial-
mesenchymal transition to organotropic colonization,
suggesting a master regulator role for hypoxia in inva-
sion and metastasis [18]. However, the molecular basis
of this process is not well understood.
Hypoxia-induced increases in invasion and metastastic
potential, and the dissemination of tumor cells from a
Figure 5 The effects of Tg737 over expression on cell adhesion, invasion, and migration in hypoxia-treated HCC cells. HepG2 and
MHCC97-H cells were treated as detailed in the legend to Figure 4. (A) An adhesion assay was used to evaluate the effects of Tg737 on adhesion.
The values of the cells incubated with medium supplemented with 10% FBS under normoxia were set at 1. (B, C) The stained membrane after
cell invasion demonstrated that Tg737 over expression in HepG2 and MHCC97-H cells led to significantly attenuated cell invasion under hypoxic
conditions compared to cells without plasmid transfection under hypoxic conditions. The data are presented as the number of invading cells for
each group. (D, E) The effects of Tg737 over expression on the migration capacity of hypoxia-treated HCC cells were investigated using a
transwell migration assay. The data are presented as the number of migrated cells for each group. I: cells without plasmid transfection; II: cells
transfected with pcDNA3.1 (−); III: cells incubated with LipofectamineTM 2000; IV: cells transfected with pcDNA3.1-Tg737. *, P< 0.05 compared to
the HepG2 controls; †, P< 0.05 compared to the MHCC97 controls. Original magnification: 200× (B, D).
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Figure 6 (A, B) HepG2 and MHCC97-H cells were treated as detailed in the legend to Figure 4. Annexin V assays revealed that the cell
viability of HepG2 and MHCC97-H cells transfected with pcDNA3.1-Tg737 and further incubated with fresh DMEM (1% FBS) for 12 h under
hypoxia were not significantly different from cells without plasmid transfection. The data from HepG2 and MHCC97-H cells transfected with
pcDNA3.1 (−) or incubated with LipofectamineTM 2000 excluded any liposome/pEGFP-C1-related effects on cell viability.I: cells without plasmid
transfection; II: cells transfected with pcDNA3.1 (−); III: cells incubated with LipofectamineTM 2000; IV: cells transfected with pcDNA3.1-Tg737.
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bloodstream or the lymphatic system are complex, multi-
step processes involving detachment from the matrix and
neighboring cells, migration through the surrounding
stroma, entry into the circulatory system, and finally arrest,
extravasation, and growth at a secondary site. This multi-
step process is mediated by several mechanisms, including
changes in gene expression, inactivation and/or the activa-
tion of genes, and enhanced genomic instability [19,20].
Several hypoxia-regulated genes have been identified thus
far, including lysyl oxidase (LOX) [21], connective tissue
growth factor (CTGF) [22], E-cadherin [23], CXCR4/SDF-1
[24], and migration inhibitory factor (MIF) [25]. However,although a general hypoxic gene signature that correlates
with poor treatment outcomes has been defined, many
invasion- and metastasis-related changes are tissue- and cell
type-specific; therefore, relevant signatures can vary from
one cell type to another [26]. Thus, further investigation is
necessary for the identification of new, HCC-specific,
hypoxia-regulated genes and for the determination of the
corresponding signaling pathways. Interference with these
specific genes to reduce hypoxia-induced invasion and me-
tastasis could contribute to the development of anti-HCC
therapies.
The Tg737 gene, a liver tumor suppressor gene of the
tetratricopeptide repeat (TPR) family, plays an important
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of the Tg737 gene has been observed in 59% of HCC
tissues [27]. Furthermore, our preliminary studies
have suggested that Tg737 is involved in HCC inva-
sion and metastasis [7,8]. In this study, we presentedFigure 7 (A) The cells were harvested with ice-cold PBS and lysed, an
analysis. The expression levels of polycystin-1 in HepG2 and MHCC97-H ce
subjected to ELISA for analysis of the secretion of polycystin-1, IL-8 and TG
under normoxia; II: cells incubated with medium supplemented with 1% FB
with 1% FBS under hypoxia. The values of the cells incubated with medium
Western blot assays showed increased polycystin-1 protein expression leve
pcDNA3.1-Tg737. (D) ELISA revealed increased polycystin-1 secretion and d
hypoxia-cultured HepG2 and MHCC97-H cells transfected with pcDNA3.1-T
100%. I: cells without plasmid transfection; II: cells transfected with pcDNA3
transfected with pcDNA3.1-Tg737. *, P< 0.05 compared to the HepG2 contrthe first evidence that the Tg737 gene has an import-
ant function in hypoxia-induced invasion and migra-
tion of HCC cells.
It has been established that cell-cell adhesion determines
the polarity of cells, participates in the maintenanced polycystin-1 levels were determined using western blot
lls were decreased in response to hypoxia. (B) The cells were
F-β1. I: cells incubated with medium supplemented with 10% FBS
S under normoxia; III: cells incubated with medium supplemented
supplemented with 10% FBS under normoxia were set at 100%. (C)
ls in hypoxia-cultured HepG2 and MHCC97-H cells transfected with
ecreased IL-8 secretion and decreased active and total TGF-β1 levels in
g737. The values of cells without plasmid transfection were set at
.1 (−); III: cells incubated with LipofectamineTM 2000; IV: cells
ols; †, P< 0.05 compared to the MHCC97 controls.
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carcinogenesis and cancer metastasis. Cell-cell adhe-
siveness is generally reduced in human cancers.
Reduced cell-cell adhesiveness allows cancer cells to
violate the local order, resulting in destruction of
histological structure, which is the morphological hall-
mark of malignant tumors. Reduced intercellular
adhesiveness is also essential for cancer invasion and
metastasis [28]. Hypoxia could facilitate tumor cell
detachment by reducing the expression of surface ad-
hesion molecules and adhesion to the extracellular
matrix [29]. As shown in our study, hypoxia-treated
HepG2 and MHCC97-H cells exhibited reduced adhe-
sion and increased invasion and migration compared
to cells under normoxic conditions. We believe that
the decreased adhesion of hypoxia-treated cells in our
study may be a reduced intercellular adhesiveness,
which may be a factor enabling malignant cells to es-
cape hypoxia with the potential to form new foci of
tumor growth. Our cell aggregation assay also showed
that hypoxia inhibited hepatoma cell aggregation in
our study (data not shown). To explore whether
Tg737 is involved in invasion and migration induced
by hypoxia, we examined the different expression
levels of Tg737 under normoxic and hypoxic condi-
tions. The data confirmed that hypoxia induced the
downregulation of Tg737 expression in HCC cell
lines. In addition, hypoxia induced changes in adhe-
sion, and the migration and invasion capacities of
HCC cells were abrogated by restoring Tg737 expres-
sion levels. Taken together, these results suggest that
hypoxia may increase the invasion and migration of
HCC cells in a Tg737-dependent manner.
The hypoxia-induced invasion and migration mediated
by Tg737 is poorly understood. A hallmark of the invasion
and migration of solid tumors is that this process requires
cell-cell/matrix molecules that influence the adhesion, mi-
gration, and invasion of cancer cells [30]. Polycystin-1 is a
large, plasma membrane receptor encoded by the PKD1
gene, which is mutated in autosomal-dominant polycystic
kidney disease (ADPKD). Polycystin-1 is involved in sev-
eral biological functions including proliferation, morpho-
genesis, and anti-apoptotic processes [31,32]. Moreover,
polycystin-1 appears to be associated with the focal adhe-
sion proteins talin, vinculin, FAK and paxillin [33]. Zhang
et al. [9] also found that polycystin-1 influences the adhe-
sion, migration, and invasion of cancer cells. As stated
above, polycystin-1 is thought to be a cell adhesion mol-
ecule, possibly a member of the immunoglobulin super-
family of cell adhesion molecules. Furthermore, preliminary
yeast 2-hybrid screens with Tg737 have identified several
potential protein partners, including polycystin 1, catenin,
P120 catenin, Snx1, and HNF4α [34]. Due to the im-
portance of polycystin 1 in the adhesion, invasion andmigration of cancer cells and as a potential protein
partner of Tg737, we hypothesized that Tg737-
mediated hypoxia-induced increases in invasion and
migration require polycystin 1. As shown in our
results, the expression of both Tg737 and polycystin 1
decreased after exposure of HCC cells to hypoxia.
Moreover, the expression of polycystin 1 was restored
under hypoxia by transfection of pcDNA3.1-Tg737.
These data suggest that the effects of Tg737 on HCC
cell migration and invasion under hypoxia may be at
least partially mediated by the polycystin 1 pathway.
A large amount of evidence suggests that some cyto-
kines and chemokines secreted by cancer cells are im-
portant modulators of migration and invasion. Among
these, IL-8 and TGF-β1 have important roles in the in-
vasion and metastasis of many types of tumors [35,36].
Furthermore, IL-8 and TGF-β1 signaling were recently
investigated during the progression of ADPKD in PKD1
mutant models [37,38]. Therefore, we hypothesized that
IL-8 and TGF-β1 may be closely associated with poly-
cystin 1 and may be required for the contribution of
Tg737 to hypoxia-induced invasion and migration in
HCC cells. To clarify this hypothesis, we analyzed the
secretion of IL-8 and TGF-β1 using ELISA and found
that IL-8 secretion and the active and total TGF-β1
levels were increased in hypoxia-treated HepG2 and
MHCC97-H cells. Furthermore, the secretion of IL-8
and both active and total TGF-β1 levels were restored
by transfection of pcDNA3.1-Tg737 under hypoxia.
These findings suggest that the Tg737-mediated hyp-
oxia-induced increases in invasion and migration are
associated with alterations in the secretion of IL-8 and
TGF-β1. IL-8 and TGF-β1 may also be important inter-
mediaries in the actions of Tg737 in HCC. However, the
precise interactions between polycystin 1, IL-8, and
TGF-β1 remain largely unexplored. Further identifica-
tion of the exact interactions may provide more details
regarding the mechanism of the effect of Tg737 on
hypoxia-induced invasion and migration. In addition,
using ELISA, we found that hypoxia decreased the secre-
tion of polycystin-1, and pcDNA3.1-Tg737 restored poly-
cystin 1 secretion under hypoxia. Future studies need to
focus on the exact mechanism of polycystin 1, IL-8, and
TGF-β1 actions in Tg737-mediated hypoxia-induced
increases in invasion and migration.
Taken together, our observations suggest that Tg737 is
involved in hypoxia-induced invasion and migration in
HCC by regulating polycystin 1, IL-8, and TGF-β1. As is
known, the best-characterized hypoxia response pathway
is mediated by hypoxia-inducible factor (HIF). Hypoxia
increases tumor glycolysis, angiogenesis and other sur-
vival responses, along with invasion and migration, by
activating relevant genes through HIF [39]. It has been
shown that the activation of HIF is not only induced by
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isms by which HIF-1 levels can be increased by dysfunc-
tional tumor suppressor genes. However, the interaction
between HIF and the Tg737 axis remains largely unex-
plored. Elucidating these details might provide more in-
formation regarding the mechanism of Tg737 effects on
hypoxia-regulated invasion and migration.
Conclusions
In this study, for the first time, we demonstrated that
Tg737 plays a key role in hypoxia-mediated invasion and
migration. The results of this study may be useful in
designing novel therapeutic interventions that block
hypoxia-dependent Tg737 expression and consequently
block HCC invasion and metastasis.
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